Company Quick10K Filing
TripAdvisor
10-Q 2021-03-31 Filed 2021-05-06
10-K 2020-12-31 Filed 2021-02-19
10-Q 2020-09-30 Filed 2020-11-05
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-02-19
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-31 Filed 2019-02-22
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-08
10-K 2017-12-31 Filed 2018-02-21
10-Q 2017-09-30 Filed 2017-11-06
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-02-17
10-Q 2016-09-30 Filed 2016-11-08
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-09
10-K 2015-12-31 Filed 2016-02-18
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-07-23
10-Q 2015-03-31 Filed 2015-05-06
10-K 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-04
10-Q 2014-06-30 Filed 2014-07-28
10-Q 2014-03-31 Filed 2014-05-06
10-K 2013-12-31 Filed 2014-02-11
10-Q 2013-09-30 Filed 2013-10-23
10-Q 2013-06-30 Filed 2013-07-24
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-02-15
10-Q 2012-09-30 Filed 2012-11-05
10-Q 2012-06-30 Filed 2012-07-26
10-Q 2012-03-31 Filed 2012-05-03
10-K 2011-12-31 Filed 2012-03-15
10-Q 2011-09-30 Filed 2011-12-06
8-K 2020-11-05
8-K 2020-08-06
8-K 2020-07-15
8-K 2020-07-09
8-K 2020-06-22
8-K 2020-06-09
8-K 2020-05-05
8-K 2020-03-27
8-K 2020-03-18
8-K 2020-02-12
8-K 2020-01-17
8-K 2019-12-16
8-K 2019-11-06
8-K 2019-08-07
8-K 2019-06-11
8-K 2019-05-24
8-K 2019-05-07
8-K 2019-03-11
8-K 2019-02-12
8-K 2018-11-07
8-K 2018-08-01
8-K 2018-06-21
8-K 2018-05-08
8-K 2018-02-14
8-K 2018-01-31

TripAdvisor Financials

TRIP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE) 450 5.1 1% 3,541 3,244 0 0 39 78 398
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU) 0% 1,497 0 0 0 0 -308
SQL Technologies (SQFL) 18% 1.5 0% 7 30 9 2 0 2 3
2-Track Global (TTG)
GB Sciences (GBLX) 23 -23% -1.8 -56% 30 16 4 -1 -17 -13 23
Nemaura Medical (NMRD) 158 -32.0 -182% 3 3 0 0 -5 -5 156
Monroe Bank and Trust (MBTF) 232 -6.6 1% 1,327 1,191 0 0 10 16 -107
Solis Tek (SLTK) 44 51% -25.8 -163% 1 7 2 1 -2 -2 44
Cumulus Media (CMLS) -94.7 -0% 0 0 0 -11 1,004
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash0184209478548368212200276351319587491455505583567614653766611612731887750673635666663655771901838
Accounts Receivable6899971038111313811197151185180151229243224180244230221189232252254230269285227205227261212
Inventory
PP&E3538394181475565122150169185195226330336335252256262371262266266440261258256493509537561
Assets08369141,1871,2591,2991,3421,4561,4481,4731,6151,8311,9561,9592,0942,2772,1982,1282,2142,3852,2772,2382,2742,4722,3482,2722,2402,3042,1922,1672,3952,5662,468
Accounts Payable122428201411912101127181926381710152511141271587102215111316
Long-Term Debt380370390385380370360350340330280270300250287287200110912091210260265230
Liabilities05425605605565725416046196096718058708349151,0368727167508806977368901,118931909850957750696888991820
Stockholders' Equity02943556276897278008528298649441,0261,0861,1251,1791,2411,3261,4121,4641,5051,5801,5021,3841,3541,4171,3631,3901,3471,4421,4711,5071,5751,648
Income Statement ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue184197213169230264255213281323354288363405415309352391421316372424439321378433458346376422428
Cost of Revenue3334455589111213161612162019161720201620242321
Gross Profit181194210166226259250208273314343276350389399297336371402300355404419305358409435355
R&D
SG&A84828888102122123134127159195149190236234242209236248205242267289208240263246220225227
Tax23243110222328626302119232424-291111841217138716101873423
Net Income48536034627056206868543663587432734551132725-84532697265350
Cash Flow ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating30627671449014571109596199200875120237-8044134221-13518174141821811
Cash Investing-0-6-7-231-179-784020-127-135-89-34-73-196611-87-65-2298-20-14-5828-13-42-45-53
Cash Financing-42170-23-19-24-112-15-14-11-6-3-580-92-94-29-10-10-114-534-37-246-1-24-4-2